MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Tag: Cutaneous sarcoidosis

Cutaneous sarcoidosis

Latest news

Tag

Dermatology

Brepocitinib Shows Promising Efficacy and Safety in Cutaneous Sarcoidosis: Results from a Phase 2 Randomized Clinical Trial

Brepocitinib, a selective TYK2/JAK1 inhibitor, demonstrated significant, dose-dependent efficacy and safety in adults with cutaneous sarcoidosis in a 16-week phase 2 randomized trial, representing a potential new targeted therapy for this c

Nov 19, 2026

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story